Indian Biotech Named To Develop Biotech-Incubator Park
This article was originally published in PharmAsia News
Bharat Biotech International of India has been named by a state government to develop the Biotech-Pharma-IT Park in Hyderabad. The park in Orissa is intended to serve as an incubator center for biotechnology firms, funded by India's Department of Biotechnology. The center is expected to be completed in eight years. Bharat Chairman Krishna Ella said the intent is to foster creation of new local entrepreneurs in biotechnology. (Click here for more
You may also be interested in...
Procter & Gamble, through its UK wellness subsidiary Nature's Best, is on-trend with new vegan vitamin D3 and iron supplements. Nature's Best has also launched three other vitamin D3 products in the country, as well as an ashwagandha supplement.
The MHRA has updated its guidance on regulatory flexibilities for medical devices and medicinal products resulting from COVID-19 to highlight how its approach differs from the EU.
The Swiss company is planning a US trial of CBSO, the first transcatheter septal occluder with a bioresorbable, metal-free frame.